Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Decrease in Fertility Rate in United Kingdom
4.2.2 Increasing Adoption of IVF Procedures
4.2.3 Favorable Government Regulations in the Country
4.3 Market Restraints
4.3.1 Social Stigma, Ethical, and Legal Issues Associated with In Vitro Fertilization
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value-USD)
5.1 By Product
5.1.1 Reagent
5.1.2 Instrument
5.1.2.1 Imaging Systems
5.1.2.2 Incubators
5.1.2.3 Cryosystems
5.1.2.4 IVF Cabinet
5.1.2.5 Ovum Aspiration Pump
5.1.2.6 Sperm Separation Systems
5.1.2.7 Micromanipulator Systems
5.1.2.8 Other Instruments
5.2 By End-User
5.2.1 Fertility Clinics
5.2.2 Hospitals
5.2.3 Other End-Users


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Vitrolife
6.1.2 CooperSurgical, Inc.
6.1.3 Merck KGaA
6.1.4 IBSA Pharma Ltd
6.1.5 Ferring Pharmaceuticals Ltd
6.1.6 Esco Medical UK Ltd
6.1.7 Kitazato Corporation


7 MARKET OPPORTUNITIES AND FUTURE TRENDS